HuGE Literature Finder
Records
1
-
30
| Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The oncologist 2022 May . Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
| Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy. BMC pulmonary medicine 2022 Mar 22 (1): 75. Wang Qi, Tan Xiaojing, Deng Guangchuan, Fu Shuai, Li Jianbin, Li Zhenxia |
| Evaluation of MET Non-Exon-14 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e101. Li X, Wang |
| NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e421. Li X, Yu J, Wang |
| Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer. Annals of translational medicine 2021 Sep 9 (18): 1475. Su Shan, Lin Anqi, Luo Peng, Zou Jianjun, Huang Zhihao, Wang Xiaojun, Zeng Yunyun, Cen Wenchang, Zhang Xianlan, Huang Huiyi, Hu Jinxing, Zhang Ji |
| Identification of a high-risk group for brain metastases in non-small cell lung cancer patients. Journal of neuro-oncology 2021 Sep . Cacho-Díaz Bernardo, Cuapaténcatl Laura Denisse, Rodríguez Jose Antonio, Garcilazo-Reyes Ytel Jazmin, Reynoso-Noverón Nancy, Arrieta Osc |
| A phase II study of osimertinib for radiotherapy-naïve CNS metastasis from non-small cell lung cancer: Results for the T790M cohort of the OCEAN study (LOGIK1603/WJOG9116L). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aug . Yamaguchi Hiroyuki, Wakuda Kazushige, Fukuda Minoru, Kenmotsu Hirotsugu, Mukae Hiroshi, Ito Kentaro, Chibana Kenji, Inoue Kohji, Miura Satoru, Tanaka Kentaro, Ebi Noriyuki, Suetsugu Takayuki, Harada Taishi, Kirita Keisuke, Yokoyama Toshihide, Nakatani Yuki, Yoshimura Kenichi, Nakagawa Kazuhiko, Yamamoto Nobuyuki, Sugio Ken |
| Co-mutations of epidermal growth factor receptor and BRAF in Chinese non-small cell lung cancer patients. Annals of translational medicine 2021 Aug 9 (16): 1321. Peng Panli, Lv Guoli, Hu Jinwei, Wang Kai, Lv Junhong, Guo Ga |
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort. Clinical lung cancer 2021 Aug . Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu |
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 66-73. Mondaca Sebastian, Lebow Emily S, Namakydoust Azadeh, Razavi Pedram, Reis-Filho Jorge S, Shen Ronglai, Offin Michael, Tu Hai-Yan, Murciano-Goroff Yonina, Xu Chongrui, Makhnin Alex, Martinez Andres, Pavlakis Nick, Clarke Stephen, Itchins Malinda, Lee Adrian, Rimner Andreas, Gomez Daniel, Rocco Gaetano, Chaft Jamie E, Riely Gregory J, Rudin Charles M, Jones David R, Li Mark, Shaffer Tristan, Hosseini Seyed Ali, Bertucci Caterina, Lim Lee P, Drilon Alexander, Berger Michael F, Benayed Ryma, Arcila Maria E, Isbell James M, Li Bob |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer. Cancer medicine 2021 Jun . Zhang Yujun, Xiong Liwen, Xie Fangfang, Zheng Xiaoxuan, Li Ying, Zhu Lei, Sun Jiayu |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Implementation of clinical sequencing for molecular profiling in patients with advanced cancer. Cancer biomarkers : section A of Disease markers 2021 Apr . Fukui Tomoya, Sakai Kazuko, Sasaki Jiichiro, Kakegawa Mikiko Ishihara, Igawa Satoshi, Mitsufuji Hisashi, Takeda Masayuki, Takahama Takayuki, Nakagawa Kazuhiko, Nishio Kazuto, Naoki Katsuhi |
| MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy. Lung cancer (Amsterdam, Netherlands) 2021 Apr 154 142-145. Wong Selina K, Alex Deepu, Bosdet Ian, Hughesman Curtis, Karsan Aly, Yip Stephen, Ho Cher |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-Small Cell Lung Cancer. Chest 2021 Apr . Roosan Moom R, Mambetsariev Isa, Pharaon Rebecca, Fricke Jeremy, Husain Hatim, Reckamp Karen L, Koczywas Marianna, Massarelli Erminia, Bild Andrea H, Salgia Ra |
| Crizotinib in Patients With MET-Amplified NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Mar . Camidge D Ross, Otterson Gregory A, Clark Jeffrey W, Ignatius Ou Sai-Hong, Weiss Jared, Ades Steven, Shapiro Geoffrey I, Socinski Mark A, Murphy Danielle A, Conte Umberto, Tang Yiyun, Wang Sherry C, Wilner Keith D, Villaruz Liza |
| PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors. Clinical lung cancer 2021 Feb . Ferrara Miriam Grazia, Martini Maurizio, D'Argento Ettore, Forcella Chiara, Vita Emanuele, Di Noia Vincenzo, Sperduti Isabella, Bilotta Mirna, Ribelli Marta, Damiano Paola, Cannella Antonella, Stefani Alessio, Pilotto Sara, Carbone Carmine, Piro Geny, Milella Michele, Tortora Giampaolo, Bria Emil |
| [A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2021 Jan . Zhang Hui, Yang Xinjie, Li Kun, Wang Jinghui, Lv Jialin, Li Xi, Zhang Xinyong, Qin Na, Zhang Quan, Wu Yuhua, Ma Li, Gai Fei, Hu Ying, Zhang Shuc |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification. Cancer research and treatment 2021 Jan . Choi Wonyoung, Park Seog-Yun, Lee Youngjoo, Lim Kun Young, Park Minjoung, Lee Geon Kook, Han Ji-Yo |
| Molecular characterization of lung carcinomas: A study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India. Journal of carcinogenesis 2021 20 17. Rao Shalinee, Anthony Michael Leonard, Chowdhury Nilotpal, Kathrotia Rajesh, Mishra Mayank, Naithani Manisha, Sindhwani Girish, Singh Ne |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| The landscape of kinase domain duplication in Chinese lung cancer patients. Annals of translational medicine 2020 Dec 8 (24): 1642. Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction. Lung cancer (Amsterdam, Netherlands) 2020 Nov . Kunimasa Kei, Oka Toru, Hara Satoshi, Yamada Noriyuki, Oizumi Satoshi, Miyashita Yoshihiro, Kamada Risa, Funamoto Tomoya, Kawachi Hayato, Kawamura Takahisa, Inoue Takako, Kuhara Hanako, Tamiya Motohiro, Nishino Kazumi, Matsunaga Takashi, Imamura Fumio, Fujita Masashi, Kumagai To |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: